These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17325739)

  • 1. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
    Esposito I; Kayed H; Keleg S; Giese T; Sage EH; Schirmacher P; Friess H; Kleeff J
    Neoplasia; 2007 Jan; 9(1):8-17. PubMed ID: 17325739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
    Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
    Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.
    Isler SG; Schenk S; Bendik I; Schraml P; Novotna H; Moch H; Sauter G; Ludwig CU
    Int J Oncol; 2001 Mar; 18(3):521-6. PubMed ID: 11179481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARCL1 suppresses metastasis in prostate cancer.
    Xiang Y; Qiu Q; Jiang M; Jin R; Lehmann BD; Strand DW; Jovanovic B; DeGraff DJ; Zheng Y; Yousif DA; Simmons CQ; Case TC; Yi J; Cates JM; Virostko J; He X; Jin X; Hayward SW; Matusik RJ; George AL; Yi Y
    Mol Oncol; 2013 Dec; 7(6):1019-30. PubMed ID: 23916135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SPARC like protein 1 (SPARCL1), extracellular matrix-associated protein is down regulated in gastric adenocarcinoma.
    Jakharia A; Borkakoty B; Singh S
    J Gastrointest Oncol; 2016 Apr; 7(2):278-83. PubMed ID: 27034797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARCL1 a novel player in cancer biology.
    Gagliardi F; Narayanan A; Mortini P
    Crit Rev Oncol Hematol; 2017 Jan; 109():63-68. PubMed ID: 28010899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonectin influences growth and invasion of pancreatic cancer cells.
    Guweidhi A; Kleeff J; Adwan H; Giese NA; Wente MN; Giese T; Büchler MW; Berger MR; Friess H
    Ann Surg; 2005 Aug; 242(2):224-34. PubMed ID: 16041213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARCL1 suppresses cell migration and invasion in renal cell carcinoma.
    Ye H; Wang WG; Cao J; Hu XC
    Mol Med Rep; 2017 Nov; 16(5):7784-7790. PubMed ID: 28944877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer.
    Yin F; Liu X; Li D; Wang Q; Zhang W; Li L
    Int J Oncol; 2013 Apr; 42(4):1305-16. PubMed ID: 23404140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma.
    Luo HL; Chiang PH; Huang CC; Su YL; Sung MT; Tsai EM; Lin CS; Chiang PH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
    Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
    Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer.
    Jiang X; Gillen S; Esposito I; Giese NA; Michalski CW; Friess H; Kleeff J
    Histol Histopathol; 2010 Dec; 25(12):1497-506. PubMed ID: 20886430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
    Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.